Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
11 November 2022
Closing Date:
23 November 2022
Location(s):
PL POLSKA (PL Poland/POLSKA)
Description:
Delivery of drugs in the drug program for the treatment of cystic fibrosis

The subject of the contract is: delivery of drugs in the drug program for the treatment of cystic fibrosis: Ivacaftorum + Lumacaftorum (Orkambi) granules (188 mg + 150 mg) x 56 sachets 18 op.

The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".

The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.

The subject of the contract is: delivery of drugs in the drug program for the treatment of cystic fibrosis: Ivacaftorum + Lumacaftorum (Orkambi) granules (188 mg + 150 mg) x 56 sachets 18 op.

The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".

The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.

Download full details as .pdf
The Buyer:
Instytut Gruźlicy i Chorób Płuc Oddział Terenowy im. Jana i Ireny Rudników w Rabce-Zdroju Instytut Badawczy
CPV Code(s):
33600000 - Pharmaceutical products